Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

CHL

₹34 -0.6 | 1.9%

Market Cap ₹186 Cr.

Stock P/E 19.6

P/B 1.3

Current Price ₹34

Book Value ₹ 26.9

Face Value 2

52W High ₹47.8

Dividend Yield 0%

52W Low ₹ 17

CHL Research see more...

Overview Inc. Year: 1979Industry: Hotel, Resort & Restaurants

Founded in 1979, Cosmopolitan Hotels Limited or CHL limited is a company operating in sectors such as hospitality, housing, and distribution.They own and operate hotels under the brands of The Suryaa in New Delhi and Hilton in Dushanbe, Tajikistan. Company promoters are Dr. Lalit Kumar Malhotra, founding father of the company and the current Chairman and Managing Director of Hotel The Suryaa, who holds 8.49% of the shares. Next are Dharam Vir Malhotra, Usha Malhotra, and Lokesh Malhotra, who are foreign promoters and hold 64.35% of the shares collectively. The company has reported a net loss of Rs. 0.2 crore for the TTM ending in March 2023 and has invited existing shareholders to purchase additional new shares at a discounted rate through a rights issue. It has also received orders valued Rs. 210 million for supplying iron raw material to prominent industrial houses.

Read More..

CHL Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

CHL Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

CHL Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 56 57 56 58 64 64 70 60 16 37 83
Other Income 3 3 2 2 1 1 1 0 1 1 0
Total Income 59 60 59 61 65 64 71 61 17 38 83
Total Expenditure 43 51 50 49 47 45 51 51 20 32 57
Operating Profit 16 10 9 11 17 19 20 10 -3 6 26
Interest 4 3 4 6 5 4 4 3 2 2 1
Depreciation 5 4 4 2 2 2 2 3 2 2 2
Exceptional Income / Expenses 0 0 0 -0 0 0 0 0 -0 0 -0
Profit Before Tax 7 2 1 2 11 13 13 5 -7 2 23
Provision for Tax 2 1 0 1 4 5 3 2 -1 0 5
Profit After Tax 5 1 1 1 7 8 10 3 -6 2 19
Adjustments 0 0 0 0 0 0 0 0 0 0 -0
Profit After Adjustments 5 1 1 1 7 8 10 3 -6 2 18
Adjusted Earnings Per Share 0.9 0 0.1 0.2 1.3 1.5 1.8 0.5 -1.2 0.3 3.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 124% 11% 5% 4%
Operating Profit CAGR 333% 38% 6% 5%
PAT CAGR 850% 85% 19% 14%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 49% 58% 32% 7%
ROE Average 15% 4% 5% 4%
ROCE Average 19% 6% 7% 8%

CHL Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 87 89 89 92 97 106 115 118 111 114 132
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 10 40 44 44 27 19 11 1 0 1 1
Other Non-Current Liabilities 8 8 8 9 13 12 10 12 10 10 10
Total Current Liabilities 30 28 31 18 21 20 24 20 20 15 12
Total Liabilities 135 164 172 164 159 156 160 151 142 140 155
Fixed Assets 54 57 53 61 60 59 59 58 56 54 56
Other Non-Current Assets 48 74 85 82 84 81 82 80 79 79 74
Total Current Assets 33 34 34 21 15 16 20 13 7 8 25
Total Assets 135 164 172 164 159 156 160 151 142 140 155

CHL Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 26 23 21 19 7 5 6 9 4 1 2
Cash Flow from Operating Activities 9 8 5 13 16 16 20 8 0 2 22
Cash Flow from Investing Activities 0 -32 -10 -5 -1 -1 -4 -1 0 -1 -3
Cash Flow from Financing Activities -13 22 3 -20 -17 -15 -13 -12 -4 -1 -6
Net Cash Inflow / Outflow -3 -1 -2 -12 -2 0 3 -5 -3 1 13
Closing Cash & Cash Equivalent 23 21 19 7 5 6 9 4 1 2 15

CHL Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.92 0.05 0.1 0.19 1.28 1.49 1.79 0.52 -1.17 0.35 3.41
CEPS(Rs) 1.79 0.2 0.86 0.58 1.69 1.89 2.21 1.02 -0.74 0.75 3.83
DPS(Rs) 0.4 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 15.94 3.23 16.28 16.82 17.74 19.3 21.01 21.49 20.32 20.74 24.15
Core EBITDA Margin(%) 23.36 11.85 11.56 15.52 25.76 28.72 26.56 16.06 -21.05 13.45 31.35
EBIT Margin(%) 20.1 9.52 8.23 15.26 23.86 26.42 24.81 12.33 -32.34 10.84 29.15
Pre Tax Margin(%) 13.38 3.48 1.05 4.16 16.76 20.79 18.55 7.88 -43.05 6.4 28.46
PAT Margin (%) 9.02 2.2 1.01 1.79 11 12.87 14.07 4.76 -39.78 5.16 22.67
Cash Profit Margin (%) 17.5 9.54 8.31 5.42 14.48 16.31 17.35 9.29 -25.02 11.08 25.44
ROA(%) 3.67 0.85 0.34 0.62 4.37 5.21 6.21 1.84 -4.39 1.35 12.67
ROE(%) 5.86 1.44 0.64 1.15 7.42 8.07 8.88 2.46 -5.61 1.69 15.2
ROCE(%) 9.42 4.16 3.1 6.02 11.06 12.66 12.91 5.8 -4.45 3.49 19.31
Receivable days 25.99 25.72 26.09 26.02 21.72 24.18 26.14 27.37 60.28 13.63 11.84
Inventory Days 25.61 27.05 30.6 28.93 25.18 23.07 20.18 22.42 76.63 33.81 17.65
Payable days 288.34 266.35 310.2 325.47 327.56 241.96 184.21 232.14 753.65 288.86 167.35
PER(x) 15.36 313.42 140.94 79.62 17.93 9.37 5.87 10.41 0 45.09 6.36
Price/Book(x) 0.89 4.48 0.9 0.9 1.3 0.73 0.5 0.25 0.31 0.75 0.9
Dividend Yield(%) 2.83 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 1.51 7.53 2.23 2.17 2.45 1.54 0.98 0.48 2.24 2.32 1.27
EV/Core EBITDA(x) 5.31 45.33 14.33 11.15 8.95 5.16 3.5 2.87 -13.12 13.91 3.99
Net Sales Growth(%) -10.39 2.8 -1.85 3.49 9.4 -0.39 9.56 -13.55 -73.18 128.27 123.7
EBIT Growth(%) -11.59 -51.28 -15.2 91.99 71.04 10.22 2.88 -57.03 -170.34 176.52 501.59
PAT Growth(%) 10.6 -74.92 -54.82 83.05 571.78 16.49 19.78 -70.79 -324.34 129.6 883.01
EPS Growth(%) 10.59 -94.98 125.76 83.03 571.82 16.48 19.79 -70.79 -324.35 129.6 883.03
Debt/Equity(x) 0.34 0.65 0.72 0.55 0.37 0.25 0.17 0.03 0.02 0.02 0.01
Current Ratio(x) 1.1 1.21 1.12 1.15 0.72 0.82 0.82 0.64 0.34 0.5 2.12
Quick Ratio(x) 0.98 1.04 0.97 0.89 0.65 0.74 0.86 0.54 0.18 0.26 1.76
Interest Cover(x) 2.99 1.58 1.15 1.37 3.36 4.69 3.96 2.77 -3.02 2.44 42.15
Total Debt/Mcap(x) 0.38 0.72 0.8 0.61 0.28 0.35 0.35 0.12 0.06 0.02 0.01

CHL Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 72.84 72.84 72.84 72.84 72.84 72.84 72.84 72.84 72.84 72.84
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 27.16 27.16 27.16 27.16 27.16 27.16 27.16 27.16 27.16 27.16
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 288.86 to 167.35days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 4% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

CHL News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....